EDITION:
- EU
- NA
Ahead of the release of Prohibition Partners upcoming Global Cannabis Report: 5th Edition, we sat down with Sebastian Zeller, Managing
SOMAÍ Pharmaceuticals, a leading EU-GMP vertically integrated Multi-Country Operator (MCO) with the most advanced cannabinoid pharmaceutical extract portfolio, has partnered
Agrify Corporation has completed the sale of its cultivation business to CP Acquisitions LLC, a company affiliated with Agrify’s former CEO, Raymond Chang.
New York’s legal adult-use cannabis market officially surpassed $1bn in annual sales last year, despite regulators ongoing efforts to tackle the flourishing black market.
US cannabis industry revenues are set to grow just 3.2% in 2025, as price compression, difficult economic dynamics and an increasingly complex political landscape put the brakes on the sector.
The US cannabis industry is experiencing rapid growth, with retail sales projected to exceed $32bn in 2024 and wholesale sales reaching nearly $12bn, according to a new study from Leaflink.
The number of active US cannabis business licenses – including those in regulated medical and recreational markets – continued to decline through the third quarter of 2024 as reductions in established markets outpaced growth in emerging ones.
Ohio’s adult-use cannabis sales have now topped $140m since the retail market launched in earnest in August, according to the
New York’s legal cannabis market could see annual sales top $6bn within two years, according to new analysis from Whitney Economics.
Telemedicine technology is driving rapid expansion of medical cannabis markets across Europe, according to Prohibition Partners’ upcoming Global Cannabis Report: 5th Edition.
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
